Coagulation Factor X Interaction with Macrophages through Its N-Glycans Protects It from a Rapid Clearance

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kurdi, Mohamad ^a   Cherel, Ghislaine ^a,b   Lenting, Peter J ^a,b   Denis, Cécile V ^a,b   Christophe, Olivier D ^a,b  

^a Dept Environ Med Natl Inst Publ HIth   (Norway)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; GLYCAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; MACROPHAGE; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

ANIMALS; BINDING SITES; FACTOR X; FEMALE; GADOLINIUM; GLYCOSYLATION; HALF-LIFE; HEPATOCYTES; HUMANS; IODINE RADIOISOTOPES; LIVER; MACROPHAGES; MICE; POLYSACCHARIDES; PROTEIN BINDING; RECOMBINANT PROTEINS; STAINING AND LABELING; TISSUE DISTRIBUTION;

MUS;

EID: 84866645193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045111     Document Type: Article

References (34)

1. Davie EW, Fujikawa K, Kisiel W, (1991) The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30: 10363-10370.
2. Furie B, Furie BC, (1988) The molecular basis of blood coagulation. Cell 53: 505-518.
3. Hertzberg M, (1994) Biochemistry of factor X. Blood Rev. 8: 56-62.
4. Jackson CM, Nemerson Y, (1980) Blood coagulation. Annu Rev Biochem 49: 765-811.
5. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S, (1990) Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76: 1-16.
6. Roberts HR, Lechler E, Webster WP, Penick GD, (1965) Survival of Transfused Factor X in Patients with Stuart Disease. Thromb Diath Haemorrh 13: 305-313.
7. Hjort PF, Egeberg O, Mikkelsen S, (1961) Turnover of prothrombin, factor VII and factor IX in a patient with hemophilia A. Scand J Clin Lab Invest. 13: 668-672.
8. Okajima K, Koga S, Kaji M, Inoue M, Nakagaki T, et al. (1990) Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects. Thromb Haemost 63: 48-53.
9. Louvain-Quintard VB, Bianchini EP, Calmel-Tareau C, Tagzirt M, Le Bonniec BF, (2005) Thrombin-activable factor X re-establishes an intrinsic amplification in tenase-deficient plasmas. J Biol Chem 280: 41352-41359.
10. Ivanciu L, Toso R, Margaritis P, Pavani G, Kim H, et al. (2011) A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia. Nat Biotechnol 29: 1028-1033.
11. Narita M, Rudolph AE, Miletich JP, Schwartz AL, (1998) The low-density lipoprotein receptor-related protein (LRP) mediates clearance of coagulation factor Xa in vivo. Blood 91: 555-560.
12. Fuchs HE, Pizzo SV, (1983) Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors. J Clin Invest 72: 2041-2049.
13. Gueguen P, Cherel G, Badirou I, Denis CV, Christophe OD, (2010) Two residues in the activation peptide domain contribute to the half-life of factor X in vivo. J Thromb Haemost 8: 1651-1653.
14. Johansson L, Karpf DM, Hansen L, Pelzer H, Persson E, (2011) Activation peptides prolong the murine plasma half-life of human factor VII. Blood 117: 3445-3452.
15. Liu-Chen LY, Chen C, Phillips CA, (1993) Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides. Mol Pharmacol 44: 749-756.
16. Levigne S, Thiec F, Cherel G, Irving JA, Fribourg C, et al. (2007) Role of the alpha-helix 163-170 in factor Xa catalytic activity. J Biol Chem 282: 31569-31579.
17. Fraker PJ, Speck JC Jr, (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 80: 849-857.
18. van Schooten CJ, Shahbazi S, Groot E, Oortwijn BD, van den Berg HM, et al. (2008) Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo. Blood 112: 1704-1712.
19. Kask L, Trouw LA, Dahlback B, Blom AM, (2004) The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J Biol Chem 279: 23869-23873.
20. Ahmad N, Gardner CR, Yurkow EJ, Laskin DL, (1999) Inhibition of macrophages with gadolinium chloride alters intercellular adhesion molecule-1 expression in the liver during acute endotoxemia in rats. Hepatology 29: 728-736.
21. Hardonk MJ, Dijkhuis FW, Hulstaert CE, Koudstaal J, (1992) Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 52: 296-302.
22. Harstad EB, Klaassen CD, (2002) Gadolinium chloride pretreatment prevents cadmium chloride-induced liver damage in both wild-type and MT-null mice. Toxicol Appl Pharmacol 180: 178-185.
23. Sakai T, Kisiel W, (1990) Binding of human factors X and Xa to HepG2 and J82 human tumor cell lines. Evidence that factor Xa binds to tumor cells independent of factor Va. J Biol Chem 265: 9105-9113.
24. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, et al. (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A 105: 5483-5488.
25. Parker AL, Waddington SN, Nicol CG, Shayakhmetov DM, Buckley SM, et al. (2006) Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108: 2554-2561.
26. Di Paolo NC, van Rooijen N, Shayakhmetov DM, (2009) Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver. Mol Ther 17: 675-684.
27. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, et al. (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132: 397-409.
28. Nawroth PP, Stern DM, Kisiel W, Bach R, (1985) Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Thromb Res 40: 677-691.
29. Bae JS, Yang L, Rezaie AR, (2010) Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1. J Biol Chem 285: 34803-34812.
30. Disse J, Petersen HH, Larsen KS, Persson E, Esmon N, et al. (2011) The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. J Biol Chem 286: 5756-5767.
31. Sen P, Nayak R, Clark CA, Gopalakrishnan R, Esmon CT, et al. (2011) Factor X binding to endothelial cell protein C receptor: comparison with factor VIIa and activated protein C. Blood. 118: 2635-2636.
32. Junghans RP, Anderson CL, (1996) The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. Proc Natl Acad Sci U S A 93: 5512-5516.
33. Chaudhury C, Mehnaz S, Robinson JM, Hayton WL, Pearl DK, et al. (2003) The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med 197: 315-322.
34. Thomas P, Birbeck MS, Cartwright P, (1977) A radioautographic study of the hepatic uptake of circulating carcinoembryonic antigen by the mouse. Biochem Soc Trans 5: 312-313.